FI953725A0 - Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi - Google Patents
Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksiInfo
- Publication number
- FI953725A0 FI953725A0 FI953725A FI953725A FI953725A0 FI 953725 A0 FI953725 A0 FI 953725A0 FI 953725 A FI953725 A FI 953725A FI 953725 A FI953725 A FI 953725A FI 953725 A0 FI953725 A0 FI 953725A0
- Authority
- FI
- Finland
- Prior art keywords
- alzheimer
- medicament
- disease
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93400303A EP0609630A1 (en) | 1993-02-05 | 1993-02-05 | Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease |
PCT/US1993/011283 WO1994017795A1 (en) | 1993-02-05 | 1993-11-19 | Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
FI953725A0 true FI953725A0 (fi) | 1995-08-04 |
FI953725A FI953725A (fi) | 1995-08-04 |
Family
ID=8214677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI953725A FI953725A (fi) | 1993-02-05 | 1995-08-04 | Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi |
Country Status (14)
Country | Link |
---|---|
US (1) | US5637768A (no) |
EP (2) | EP0609630A1 (no) |
JP (1) | JPH08506577A (no) |
AU (1) | AU682330B2 (no) |
CA (1) | CA2152796A1 (no) |
FI (1) | FI953725A (no) |
HU (1) | HUT73173A (no) |
IL (1) | IL107737A (no) |
MX (1) | MX9400911A (no) |
NO (1) | NO953072L (no) |
NZ (2) | NZ280983A (no) |
TW (1) | TW383337B (no) |
WO (1) | WO1994017795A1 (no) |
ZA (1) | ZA938836B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005510524A (ja) * | 2001-11-16 | 2005-04-21 | アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド | ポリアミン経路の調節による神経変性障害の治療 |
EP1448183A2 (en) * | 2001-11-16 | 2004-08-25 | ALS Therapy Development Foundation, Inc. | Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
CN111362828A (zh) * | 2020-03-30 | 2020-07-03 | 山西医科大学 | 一种18f标记的氟丙酰化鸟氨酸及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2041815T3 (es) * | 1988-02-05 | 1993-12-01 | Merrell Dow Pharmaceuticals Inc. | Un procedimiento para la obtencion de derivados de ornitina 5-sustituidos. |
-
1993
- 1993-02-05 EP EP93400303A patent/EP0609630A1/en not_active Withdrawn
- 1993-11-19 EP EP94901621A patent/EP0682515A1/en not_active Ceased
- 1993-11-19 NZ NZ280983A patent/NZ280983A/en unknown
- 1993-11-19 NZ NZ258461A patent/NZ258461A/en unknown
- 1993-11-19 US US08/491,968 patent/US5637768A/en not_active Expired - Fee Related
- 1993-11-19 CA CA002152796A patent/CA2152796A1/en not_active Abandoned
- 1993-11-19 WO PCT/US1993/011283 patent/WO1994017795A1/en not_active Application Discontinuation
- 1993-11-19 JP JP6518005A patent/JPH08506577A/ja active Pending
- 1993-11-19 AU AU56143/94A patent/AU682330B2/en not_active Ceased
- 1993-11-19 HU HU9502320A patent/HUT73173A/hu unknown
- 1993-11-22 TW TW082109808A patent/TW383337B/zh active
- 1993-11-24 IL IL10773793A patent/IL107737A/en not_active IP Right Cessation
- 1993-11-25 ZA ZA938836A patent/ZA938836B/xx unknown
-
1994
- 1994-02-04 MX MX9400911A patent/MX9400911A/es unknown
-
1995
- 1995-08-04 NO NO953072A patent/NO953072L/no not_active Application Discontinuation
- 1995-08-04 FI FI953725A patent/FI953725A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL107737A (en) | 1998-12-27 |
ZA938836B (en) | 1994-08-02 |
NZ258461A (en) | 1997-03-24 |
IL107737A0 (en) | 1994-02-27 |
HU9502320D0 (en) | 1996-05-28 |
NO953072D0 (no) | 1995-08-04 |
TW383337B (en) | 2000-03-01 |
FI953725A (fi) | 1995-08-04 |
EP0682515A1 (en) | 1995-11-22 |
JPH08506577A (ja) | 1996-07-16 |
AU5614394A (en) | 1994-08-29 |
US5637768A (en) | 1997-06-10 |
WO1994017795A1 (en) | 1994-08-18 |
HUT73173A (en) | 1996-06-28 |
EP0609630A1 (en) | 1994-08-10 |
NZ280983A (en) | 1997-07-27 |
MX9400911A (es) | 1994-08-31 |
NO953072L (no) | 1995-08-04 |
AU682330B2 (en) | 1997-10-02 |
CA2152796A1 (en) | 1994-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0735870A4 (en) | USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
NO981911D0 (no) | Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom | |
IT9022471A0 (it) | Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente | |
NO306850B1 (no) | Anvendelse av 5-halo-2-pyrimidinon-deoksyribose eller 5-halo-2-pyrimidinon for fremstilling av et medikament for behandling av leversykdom | |
CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
HUP9903906A3 (en) | Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
ES2161238T3 (es) | Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas. | |
FI962685A0 (fi) | 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi | |
IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
FI953725A (fi) | Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi | |
DK0642338T3 (da) | Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom | |
NO307126B1 (no) | Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom | |
AU8195091A (en) | Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease | |
ZA947262B (en) | Use of transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease | |
FI951041A (fi) | (S)-(-)-alfa-etyyli-2-okso-1-pyrrolidiiniasetamidin käyttö valmistettaessa farmaseuttinen valmiste ahdistuksen hoitoon | |
KR940022019U (ko) | 남성물리치료기 | |
SI0664121T1 (en) | Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of atherosclerose and ischaemic heart disease | |
LV5177A3 (lv) | Preparats "eridons" govju endometritu profilaksei un arstesanai | |
SE9300795D0 (sv) | Ny princip foer smaertbehandling | |
ITTO920656A0 (it) | Sedia per operativita' chirurgica | |
LV5179A3 (lv) | Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai | |
KR950000466U (ko) | 남성물리치료기 | |
SI1007040T1 (en) | Use of phanquinone for the treatment of alzheimer's disease | |
KR930004437U (ko) | 무좀치료 보조장치 | |
SE8904189D0 (sv) | Anordning foer straeckbehandling av en maenniskas rygg |